Skip to main content
Equibles

GRANDFIELD & DODD, LLC

Position in INCY — Incyte Corp

CIK 1308016 NEW YORK, NY
Back to INCY Full portfolio

Position in INCY

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$2,360,381
+$394,685 QoQ
Shares Held
20,822
-0.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#310
of 855 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in INCY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GRANDFIELD & DODD, LLC holds $46,143,038 across 12 Biotechnology names. INCY ranks #4 (5.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 36,628 $22,839,023
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 24,838 $12,337,779
3 IONS
Ionis Pharmaceuticals Inc
 37,077 $2,939,835
4 INCY
Incyte Corp
This page 		20,822 $2,360,381
5 EXEL
Exelixis, Inc.
 27,109 $1,475,000
6 BMRN
Biomarin Pharmaceutical Inc
 18,243 $1,043,864
7 GMAB
Genmab A/S
 37,633 $1,033,778
8 ALNY
Alnylam Pharmaceuticals, Inc.
 3,204 $964,500

All Filings in INCY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,360,381 20,822
2026-03-31 $1,965,696 20,885
2025-12-31 $2,083,355 21,093
2025-09-30 $1,787,540 21,077
2025-06-30 $1,418,046 20,823
2025-03-31 $1,275,485 21,065
2024-12-31 $1,395,697 20,207
2024-09-30 $1,290,602 19,525
2024-06-30 $1,146,627 18,915
2024-03-31 $1,071,605 18,810
2023-12-31 $1,154,708 18,390
2023-09-30 $1,043,961 18,071
2023-06-30 $1,095,973 17,606
2023-03-31 $1,257,136 17,395
2022-12-31 $1,368,652 17,040
2022-09-30 $1,060,575 15,915
2022-06-30 $1,182,473 15,565
2022-03-31 $1,221,479 15,380
2021-12-31 $1,094,394 14,910
2021-09-30 $903,769 13,140
2021-06-30 $1,081,911 12,860
2021-03-31 $1,027,659 12,645
2020-12-31 $1,090,294 12,535
2020-09-30 $1,092,674 12,176
2020-06-30 $1,242,753 11,953
2020-03-31 $819,663 11,193